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Introduction
During brain development, neuroepithelial
cells give rise successively to neurons, astro-
cytes, and oligodendrocytes. At the beginning
of the century, while studying the presence of
dividing cells in the embryonic brain, Ramón
y Cajal found that neuroepithelial cells sur-
rounding the ventricles divide, and should
thus be at the origin of the future cells that
build this organ. The origin of the neural cells
that appear during the neural-tube formation
was debated to identify whether multipotent
cells able to generate the three cell pheno-
types exist, or whether three restricted prog-
enitors cohabit to produce either neurons,
astrocytes, or oligodendrocytes. In the study
of neural retina development, it appeared that
a unique pool of cells gives rise to the differ-
ent neuron phenotypes and then to astrocytes
in a chronological mode. Clonal analysis at a
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Recent data show that the final events of mammalian brain organogenesis may depend in part
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different developmental time of the proliferat-
ing zone by infection with retrovirus carrying
a reporter gene revealed that the retina con-
tains multipotent cells capable of producing
all cell phenotypes (1). Similar observations
were made with the developing cortex (2).
These data suggest that the brain is built by
multipotent cells that are able to renew for an
extended period of time. Multipotentiality
and long-term renewal were defined as stem-
cell characteristics (3). Renewal means that
the stem cells can proliferate for an extended
period of time and conserve their characteris-
tics (multipotentiality and renewal). 1Neural
stem cells were isolated in vitro in 1992 (4)
from various regions of the developing mouse
brain, including the striatum, cortex, mesen-
cephalon, and spinal cord. Thanks to the abil-
ity to isolate neural stem cells (NSC) in
serum-free medium and to study them, NSCs
provide(d) numerous new insights on neuro-
genesis, as reviewed in refs. 5–12.
During the last two years, many studies
describing the control of intrinsic and extrin-
sic factors on NSC proliferation have been
published. Consequently, these findings have
opened new perspectives for NSCs. This
review focuses on the molecular control of
mammalian neural stem-cell renewal of dif-
ferent central nervous system (CNS) loca-
tions, including the spinal cord, the
telencephalon, and the retina. The similarities
and differences between these stem cells may
reveal important mechanisms that are specific
to neural stem cells. In this article, only the
factors that were shown to act directly on
neural stem cells and, in certain cases, on
neural progenitors*, are discussed. We first
reveal the factors that are essential for NSC
survival and renewal, and then the epigenetic
and intrinsic factors that modulate NSC pro-
liferation. Finally, because cell renewal
depends on the regulation of the mitotic cycle,
the tumor suppressors known to control
stem-cell renewal are presented. In this
description, data showing how the NSCs
acquire new characteristics during develop-
ment and adulthood are discussed.
Multipotent Neural Stem Cells 
in the Developing and 
the Adult CNS
As described previously, NSCs can be iso-
lated from various regions of the CNS (4). Iso-
lation can be achieved in serum-free medium
containing epidermal growth factor (EGF).
NSCs proliferate and form large clusters
known as spheres or neurospheres. Clonal
analysis revealed that each sphere originates
from one cell (13), providing an easy model to
test stem-cell renewal and expansion. Indeed,
a dissociated sphere is able to generate sev-
eral other spheres, with the majority remain-
ing multipotent (Fig. 1). This procedure can
be repeated several times, thus revealing the
stem-cell characteristic of renewal. It was also
shown that clones of human telencephalic
fetal stem cells can renew for at least 2 yr; the
renewal capacity was demonstrated by sub-
cloning procedures (14). As we will see, NSCs
can be isolated early during development
with fibroblast growth factor-2 (FGF-2)
(15–17), and then later, with EGF. It appears
that NSCs change their competence along
development to respond to environmental
cues. Also, certain adult neural stem cells pre-
sent new characteristics in comparison to fetal
NSCs, showing that NSCs change their bio-
logical behavior throughout life. Neurosphere
isolation is not the unique in vitro technique
to study NSCs. Infections with replication-
incompetent viruses as well as monolayer cul-
tures are also effective methods to investigate
the biology of NSCs. It should be noted that,
in a comparison of monolayer and neu-
rosphere methods, there is no evidence that
these two techniques allow the isolation of the
same pool of NSCs.
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* The term “neural progenitor” regroups all non-differ-
entiated cells able to proliferate for a long period of time.
Stem cells, bi-potent, and unipotent highly proliferative
cells composed this group.
In the 1960s, Altman and Das (18) stated
that the adult rodent brain can generate new
neurons. However, these observations were
considered as rare events, and thus received
little interest. In 1982, Bayer et al. (19)
revealed that adult neurogenesis is a robust
phenomenon in the olfactory bulb and the
dentate gyrus, rendering the study of adult
neurogenesis attractive. If new neurons are
generated throughout life, stem cells should
still be present in adult rodent brains. The
groups of Alvarez-Buylla and Luskin revealed
through transplantation studies that the ante-
rior part of the subventricular zone (SVZ) is at
the origin of the neurons reaching the olfac-
tory bulb (20–22). In vitro isolation of adult
NSC was achieved by Reynolds and Weiss
(23), showing that a population of striatal
cells surrounding the mouse ventricle is able
to proliferate in response to EGF in serum-
free medium and these cells have all the char-
acteristics of a stem cell. NSCs were also
isolated in other brain areas, including the
retina (24,25). The nature of stem cells (astro-
cytes vs ependymal cells) is still under debate
(26–28). Adult NSCs have certain particulari-
ties that are distinct from fetal ones. In the fol-
lowing sections, the necessary events
controlling NSC survival and renewal during
development and adulthood are discussed.
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Fig. 1. A single stem cell is able to generate a cluster of neural progenitors termed “sphere.” Under condi-
tions that induce cell differentiation, this sphere generates neurons, astrocytes, and oligodendrocytes, revealing
the multipotentiality of the stem cell. The renewal capacity can be tested by dissociating the sphere and incu-
bating the single cells with medium known to induce the division of stem cells. If one or more new multipotent
spheres appear, renewal has occurred. The generation of more than one multipotent sphere attests to the expan-
sion of the stem cell through symmetric division (one mother stem cell gives rise to two daughter stem cells),
whereas the presence of one sphere reveals stem-cell renewal by asymmetric division. If no spheres are gener-
ated, the initial cell at the origin of the primary sphere is restricted in its potential to renew (black cross), and is
not considered as a stem cell. It remains unclear to what extent renewal testing is needed to ascertain the iden-
tity of a stem cell. In fact, the more renewal capacity is tested, the more confident we are.
Epigenetic Factors Controlling 
Stem-Cell Renewal and Expansion
The Factors Essential for NSC Survival 
and Renewal: The Triad 
EGF-FGF-2-IGF-I
In 1992, Reynolds and Weiss revealed that
stem cells can be isolated from all the regions
investigated at E 14 of the developing mouse
CNS in the presence of EGF. Similar results
also seem to be intrinsic to the developing
retina (29), but long-term studies and sub-
cloning are necessary to reveal the characteris-
tics of these cells. Interestingly, mouse CNS
stem cells, including those of the spinal cord,
can also be isolated in the presence of FGF-2
(17,30–32). The existence of EGF- and FGF-2-
responsive stem cells raises the question of
their lineage relationships. Several studies
have addressed whether two different NSCs
exist or whether the NSC population responds
to the two different growth factors (17,30,33).
The work of Tropepe et al. (1999) showed that
at low cell-culture density, EGF and FGF-2
have additive actions on E 14.5 NSCs, but such
a phenomenon did not occur at high cell-cul-
ture density. Interestingly, FGF-2- but not EGF-
responsive stem cells can be isolated at E 8.5.
These results suggest that two populations of
NSCs exist, and that yet another factor controls
NSC proliferation or survival. Contradictory
results nonetheless indicate that one stem cell
exists (30). In fact, early NSCs acquire a new
competence to respond to EGF (15). Some
NSCs may lose their ability to react to FGF-2
alone, which would explain that at low cell
density, two populations of NSCs are observed
(17). Ultimately, a thorough understanding of
the factors that regulate survival and/or prolif-
eration of NSCs will be necessary to determine
whether there are single vs multiple NSC pop-
ulations in the forebrain.
CNS development is dramatically altered in
the absence of FGF-2 or EGF receptor (EGF-R)
(34–36). The lack of FGF-2 expression leads to
marked brain growth failure starting at E 8.5,
at the time when FGF-2-responsive stem cells
can be isolated (17), whereas the EGF-R actions
during CNS development appear to be
required later (at E 13.5), when EGF-responsive
stem cells appear to be active. As a result, a
strong correlation exists between the time of
brain defect resulting from the absence of FGF-
2 or EGF-R and the time of stem-cell activa-
tions by FGF-2 and EGF. In an in vitro model
using organotypic cultures, EGF-R was
observed to be temporally expressed, with an
increasing expression occurring during devel-
opment (37), predominantly in the SVZ vs the
VZ. Misexpression of EGF-R by replication
incompetent retroviral vectors accelerates the
appearance of EGF-responsive stem cells, and
is involved in a switch from neuron to glia gen-
eration, probably acting directly on the stem
cell. In support of these data, addition of FGF-2
to E12 cortical explant cultures accelerated the
appearance of EGF-responsive stem cells (38).
Confirming these results, FGF-responsive stem
cells are isolated predominantly at early devel-
opmental stages, and mainly generate neurons
in comparison to EGF-responsive stem cells,
which are predominantly present at later
stages and generate astrocytes and more oligo-
dendrocytes (39). During spinal cord develop-
ment (E 10.5), the neuroepithelial cells express
receptors for the FGF family but not for EGF
(16). Later (at E 14) EGF-responsive stem cells
can be derived from this region. It appears that
EGF and FGF-2 are essential for stem-cell pro-
liferation throughout brain development, and
participate in the cell fate decision of progeni-
tors at a stem-cell level. Nonetheless, these fac-
tors require the presence of another factor in
order to be active: insulin-like growth factor-I
(IGF-I).
During early and midgestation brain devel-
opment, both IGF-I ligand and receptors are
present in rodent neuroepithelial cells at a time
when FGF-2 and EGF are present, suggesting
that these factors may interact to control NSC
activity. Indeed, IGF-I was recently shown to
be an essential factor in stem-cell proliferation:
in the absence of IGF-I, EGF and FGF-2 are
unable to induce stem-cell proliferation. In
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vitro NSC generation is dose-dependent. If the
number of proliferating NSCs is coupled to the
IGF-I level, we can hypothesize that the final
neural-cell number should depend on the con-
centration of IGF family peptides present dur-
ing brain organogenesis. Deficits in brain
development in IGF-I and IGF-I-R-deficient
mice support this hypothesis (40–42). The tem-
poral actions of IGF-I and EGF during devel-
opment are well-correlated, suggesting a close
interaction between these factors to sustain
NSC proliferation, whereas FGF-2-responsive
NSCs are probably controlled by another factor
in addition to IGF-I. Insulin is one possible
candidate, and is present throughout brain
development. Supporting this view, in absence
of IGF-I, physiological concentrations of
insulin can induce stem-cell proliferation in the
presence of FGF-2 or EGF (personal data). One
of the actions of insulin was reported to control
the early events of chick eye development (43).
Moreover, insulin injection into the newborn
chick induces neural-progenitor proliferation
in the retinal margin (44), an area where stem
cells are located (45).
Mouse null-mutation studies have revealed
that IGF-I, FGF-2, and EGF are necessary for
brain growth, but they have not demonstrated
specific functions for each of these growth fac-
tors. The use of a neurosphere system is a pow-
erful tool to understand the function and the
mechanism of factors that support stem-cell
proliferation (see Fig. 1). Studies testing contin-
uous vs delayed administration of IGF-I, FGF-
2, and EGF on mouse NSCs showed that IGF-I
and EGF had no effect on NSC survival, and
FGF-2 promoted NSC survival or mainte-
nance. Also, short-term exposure to IGF-I
induced the proliferation of NSCs in the pres-
ence of EGF, but not of FGF-2, through an
autocrine secretion of IGF-I (31). These experi-
ments show that EGF and FGF-2 have different
functions and actions on NSCs. These differ-
ences may explain how NSCs can be quiescent
or active. For instance, FGF-2 may maintain
NSC survival, whereas the level of IGF-I can
stimulate proliferation and determine the
number of precursors generated.
In human fetal stem cells, the presence of
both EGF and FGF-2 is required to allow stem-
cell survival and proliferation in vitro, contrary
to what is observed with murine fetal stem
cells that require only one of these factors (14).
The different actions observed for EGF and
FGF-2 in murine cells may have been rein-
forced during evolution, with FGF-2 acting
predominantly on stem-cell survival and EGF
on proliferation. This hypothesis has not yet
been tested. Another study using human fetal
neural stem cells revealed that the Leukemia
Inhibitory Factor (LIF) is required to allow
stem-cell renewal (46). In fact, it is possible that
LIF exerts a survival action on stem cells, as
demonstrated on other neural cells (47–49).
Human NSCs are delicate, and the presence of
LIF may compensate for side effects such as
cell dissociation. LIF may protect stem cells
from entering into a senescent state. Interest-
ingly, the LIF-R were also shown to have an
effect on NSCs of adult mice. Indeed, the num-
ber of spheres generated from the SVZ of LIF-
R–/– mice is lower in comparison to wild-type
animals, as well as the number of interneurons
in the olfactory bulb (50). In vivo and in vitro
ciliary neurotrophic factor (CNTF) stimulation
of SVZ cells increases the number of spheres. It
is known that CNTF acts through the LIF-R. In
fact, CNTF acts either at low concentration by
binding the complex CNTF-Rα, gp130, and
LIF-R, or at high concentration on the dimer
gp130/LIF-R (51). These results suggest that
the depletion of NSCs in the SVZ is responsible
for the loss of neurons in the olfactory bulb.
Single-sphere analyses have revealed that
CNTF maintains multipotentiality and
increases stem-cell renewal. Moreover, CNTF
seems to counteract the EGF action that leads
cell fate toward a glial phenotype (50). CNTF
appears to play a role in maintaining stem-cell
characteristics.
In summary, it appears that EGF, FGF-2 and
IGF-I are essential for mouse NSC regulation
throughout development, and their interac-
tions remain, unsolved. LIF could play an
essential role in the maintenance of human
NSCs, an action also identified in adult mice. It
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is also possible that LIF exerts an effect on
NSCs during early CNS development. Indeed,
as we have seen, NSCs can only be isolated at
E 8.5, and not before. These results suggest that
other factors are necessary to isolate the most
primitive NSCs. One possible candidate is LIF.
In addition to the actions previously described,
LIF allows the in vitro isolation of a pluripo-
tent NSC able to generate various cell pheno-
types and restricted NSCs from the mouse
embryonic stem (ES) cells (52). Indeed, when
ES cells are stimulated with LIF and FGF-2,
they generate “spheres” that are capable of
generating cells of the endo-, meso-, and the
neuroectoderm. When these pluripotent
spheres were dissociated and the single cells
plated in the sole presence of FGF-2, neu-
rospheres appeared. They are able to renew,
but only generate neurons, astrocytes, and
oligodendrocytes. It appears that between the
ES cell and the NSC, an intermediate state is
required, and that the intermediate state neces-
sitates LIF. These results suggest that LIF could
be an important regulator of NSCs during
early induction of the CNS. The level of the
NSC pool size during adulthood could already
be determined during CNS development.
The Notch Pathway Is Essential 
for NSC Renewal
In order for a NSC to conserve its status, sur-
vival and proliferation are not sufficient. Epi-
genetic and intrinsic factors that prevent cell
differentiation are also required. If we consider
neurogenesis from invertebrates to mammals,
Notch is certainly one of the most conserved
pathways for the maintenance of the progeni-
tor status at certain periods of development.
Notch is a receptor that is present in neural
progenitors, and its activation was first
observed to prevent cell differentiation (53).
When activated by ligands such as Delta and
Jagged (in mammals), the intracellular domain
of Notch (Notch-IC) is cleaved by presinilin
(Fig. 2). Formation of Notch-IC can also occur
independently of presinilin. Notch-IC activates
gene expression through the binding of RBP-jk
(54);. For Notch1 –/–, or RBP-jk –/– knockout
mice, almost no neural stem cells were identi-
fied in E 10.5 and E 8.5 forebrain embryos, and
a reduction of 93% of the stem-cell number in
presenilin –/– mice was observed (55). These
results suggest that the Notch pathway is
essential for the formation of neural stem cells
during this period. Regarding stem-cell
renewal, when presenilin-1 is reduced or
absent, a drastic reduction of the stem-cell
number is observed when primary neu-
rospheres were subcloned (see Fig. 1). Similar
results were reported when neurospheres
were derived from ES cells that were deficient
for the RBP-jk protein (52,55). The target gene
of Notch-IC/RBP-jk transactivation, Hes-1,
also appears to play an important role in NSC
renewal. In Hes1–/– mice, a 2.5-fold decrease
in the stem-cell number was observed at E
10.5. The Hes1–/– spheres have a normal size,
indicating that the proliferation of the progen-
itors derived from the stem cell is not affected
by a loss of Hes-1 expression. However, the
renewal ability is reduced by approx 50% (56).
These results show that Hes-1 mediates Notch
signaling, but that other genes may also be
involved in such transduction—considering
that the loss of RBP-jk results in a complete
abolition of Notch signaling, whereas Hes-1
loss leads to partial disruption. Confirming
this hypothesis, Hes-1 is present at normal
level in RBP-jk–/– mice, whereas Hes-5 is
downregulated in SVZ cells (55). Moreover,
the generation of neurospheres is drama-
tically reduced in double knockout mice
Hes1–/–/Hes5–/–, in comparison to single
deficient mice (57). It appears that at least both
Hes-1 and Hes-5 mediate Notch signaling in
neural stem cells. When progenitors derived
from stem cells of presinilin1–/– mice were
induced to differentiate, a higher percentage of
neurons and astrocytes was observed in com-
parison to wild-type animals, suggesting that a
decreased activity of the Notch pathway
induces a loss of the non-differentiated state.
Forced Notch-1 expression in periventricular
regions of the developing mouse brain (E 14.5)
results in the reduction of neuron formation,
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supporting the role of Notch in preventing cell
differentiation (58). Such action was also
reported for cerebellar granule neuron precur-
sors through the activation of the Notch2
receptor (59). These results contrast with those
showing that overexpression of Notch1-IC or
Notch3-IC in adult hippocampal stem-cell cul-
tures (following the culture procedure of [24])
leads to the formation of astrocytes under pro-
liferating conditions (60). It is known that hip-
pocampal stem-cell cultures contain a variety
of precursors and progenitors (neuroblasts,
glioblasts, stem cells, or bi-potent precursors).
thus from this study, it is not clear which cells
are at the origin of astrocytes following over-
expression of the Notch1-3 pathway. The
experiments did not test whether Notch mis-
expression acts directly on stem cells or their
derived progenitors. However, these results
indicate that Notch can also intervene in favor-
ing cell differentiation, as it was reported in
vivo for the formation of cortical astrocytes
(58), Müller cells in the retina (61), or Schwann
cells in the peripheral nervous system (PNS)
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Fig. 2. This schema proposes several mechanisms necessary for a NSC to maintain the characteristics of
multipotentiality and renewal. A non-differentiated state is probably conserved when a subtle level of Notch
activation occurs between the stimulation by Delta/Serrate and the inhibition by Numb. First Delta binds to
Notch, which is then cleaved in the cell by the presinilin protease, releasing the Notch-IC domain that com-
plexes RBP in the nucleus. The result is the activation of Hes1 and Hes5 genes. Both Hes1 and Hes5 are neces-
sary to maintain the stem-cell state. The downstream effectors preserving stem-cell identity are unknown.
Musashi-1 might control the exit out of the stem-cell state by inhibiting Numb synthesis. Groups of receptors are
involved in the control of stem-cell proliferation. Three receptors were identified to be necessary to maintain
stem-cell renewal: FGF-R1, EGF-R, and IGF-I-R. The corresponding ligands are indicated here. In regard to the
adult hippocampal NSC, cystatin-C controls renewal, and the receptor has not yet been identified.
(62), but not for olfactory bulb glia (58). Varia-
tions in mouse age, cell populations trans-
duced to express Notch, and brain areas
studied may explain the differences between
these studies. However, these results are not
necessarily contradictory, considering that
radial glia (63), periventricular astrocytes (26),
and Müller cells in the chick retina (64) may
have a population that has retained some NSC
characteristics. Nonetheless, the long-term re-
newal of these cells has still not been
described. In fact, it is possible that, rather than
driving stem cells to a glial fate, Notch
increases the population by symmetric divi-
sion—which later would express glial mark-
ers—because stem cells seem to be already
committed to generate more glia than neurons
at this stage.
The potential role of Notch on stem cells was
also identified in living embryonic retinal
slices (65). During CNS development, NSCs
are known to divide asymmetrically to give
rise to one stem cell and one neuroblast, with
the plane of division parallel to the surface of
the ventricle (66), whereas when one stem cell
divides symmetrically to generate two stem
cells, the plane is perpendicular. This rule is
not absolute (see the percentage of mitotic cells
that are neither in a horizontal or in a vertical
plane in ref. 67). Studies of stem cells during
retinal and cortical neurogenesis have revealed
that the apical cell that gives rise to a new stem
cell expresses Numb, whereas the basal cell
does not (68). Both cells express Notch, and
Numb is believed to be implicated in the stem-
cell-state maintenance of the apical cell (69).
Indeed, in the developing rat retina or mouse
cortex, when division occurs on a vertical
plane, two stem cells are generated, both con-
taining an equal amount of Numb protein in
their apical pole (65,69). When division sepa-
rates cells on a horizontal plane, only the apical
cell conserves Numb, and only this cell main-
tains stem-cell characteristics. Moreover,
Numb knockout mice have profound defects
in the neural tube, characterized by an early
appearance of neurons in the telencephalon,
which suggests that the progenitor state was
altered in these animals, provoking an
advanced formation of neurons (70). All these
experiments suggest that Numb may partici-
pate in retaining the stem-cell state. However,
recent data revealed that Numb decreases the
Notch activation pathway. When Numb is mis-
expressed in cells expressing Notch and acti-
vated by the ligand Delta, the transactivation
of Hes-1 by Notch is repressed by Numb (71),
as was previously observed in the Drosophila
(72). Numb is believed to bind the PEST
sequence of the Notch-IC preventing Notch-
pathway activation (demonstrated in avian
CNS, [73]), as well as by preventing Notch-1
transactivation of the HES1 promoter (71).
Intriguingly, it seems that the maintenance of
the stem-cell state by Numb is linked to an
inhibition of the Notch activation. We previ-
ously described Notch as necessary for stem-
cell renewal (55). How can we reconcile these
findings? First, Numb and Notch are not
unique to control the stem-cell state. Other fac-
tors, such as Emx2, can have redundant actions
such as the different forms of Notch-1, -2, and -
3; or the Numb-like protein. Or, different levels
of Notch activation might result in different
cell states. For instance, low activation of
Notch caused by the presence of Numb may
lead to a stem-cell state, whereas higher activa-
tion leads to the generation and the limited
proliferation of committed neural precursors
(neuroblasts early, and glioblasts late in devel-
opment). Perhaps, during the absence of
Numb, Notch alone cannot maintain the stem-
cell state, but may allow the amplification of
neuroblasts, resulting in an accelerated neuro-
genesis. Notch would only be necessary to
amplify a non-differentiated cell, a stem cell, or
a precursor, with other factors controlling their
specific fate. Supporting this hypothesis,
Notch overexpression in eye Drosophila pro-
vokes an enlarged eye and not a non-differenti-
ated mass (74), and overexpression of Notch in
hematopoietic stem cells allows in vitro prolif-
eration of these stem cells without altering the
differentiation capacity of the derived progeni-
tors to differentiate (75). I believe that this
hypothesis is compatible with apparent contra-
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dictory observations in neurogenesis studies
involving Numb and Notch misexpression.
Another modulator of this pathway was
recently identified: musashi. Mouse Musashi-
1 was first identified as a regulator of asym-
metric division necessary for the formation of
sensory neurons in Drosophila (56). In mam-
mals, Musashi was shown to be an RNA-
binding protein, and is believed to regulate
posttranscriptional events that control cell
differentiation (76). Isolation of fetal human
neural cells that express Musashi-1 revealed
that the majority of them are also positive for
the marker of undifferentiated cells, nestin,
and have the potential to proliferate (77).
Moreover, cell isolation based on Musashi
expression allows a 10-fold enrichment of
stem cells from cell culture and a 100-fold
enrichment from cells isolated directly from
the parenchyma, showing that NSCs contain
Musashi (77). A target of mouse Musashi was
recently identified: Musashi binds the 3′-
untranslated sequence (UTR) of the numb
mRNA (71). Overexpression of Musashi
results in the downregulation of the Numb
protein level but not of its mRNA. In fact the
promoter activity of numb mRNA is reduced
by approx 75% in the presence of Musashi.
Moreover, the presence of Musashi slightly
activates (fivefold) the Hes1 promoter and
enhances Notch activation on this Hes-1 pro-
moter. The Hes1 promoter is also the target of
Numb that inhibits the transactivation (71).
This series of observations suggests that simi-
lar phenomena could occur in NSCs, and that
Musashi could be an intrinsic factor control-
ling the non-differentiated state. These
actions have not yet been demonstrated in
neural stem cells and under physiological
conditions, but nonetheless, they point out an
important possible mode of stem-cell-state
regulation. Because musashi is also expressed
in neuroblasts (78,79), and blocks Numb pro-
tein synthesis, it is possible that musashi
intervenes in the transition of the stem-cell
state toward the neuronal fate. Loss-of-
expression studies of musashi should reveal
its role.
Does a Link Exist Between NSC Mitogens
and the Notch Pathway?
What is the link between the Notch pathway
and the mitogens that allow NSC renewal?
Some studies show a possible cross-communi-
cation between these pathways. Interestingly, a
link between the FGF family and the Notch
pathway was recently observed in neuroep-
ithelial cells (80). The stem cell’s characteristics
were not studied in these experiments, but
FGF-1 or FGF-2 prevented neurogenesis of
neuroepthelial cells, upregulated the expres-
sion of Notch-1 and Notch-3, and decreased
Delta 1. Moreover, FGF action is blocked when
Notch-1 expression is suppressed by anti-sense
(80). These observations are in agreement with
the results of Hitoshi et al. (55) and suggest
that FGF-2 stimulates stem-cell expansion
(symmetric division) through the activation of
the Notch pathway. EGF probably acts in a
similar fashion (although this has not been
confirmed) because ectopic EGF stimulation
on retinal explant expand eye neuroepithelial
cells (12,29,81), and prevents cell differentia-
tion (or prolong the non-differentiated state)
(29). The maintenance of precursor prolifera-
tion by epigenetic stimulation through the acti-
vation of the Notch pathway is also
documented for cerebellar granule neuron pre-
cursors stimulated by sonic hedgehog (Shh)
(59). Shh was initially identified as a factor
secreted by the notochord that ventralizes the
CNS (82–85) and more recently, as a mitogen
for neural precursors suggested by mutation of
the Shh signaling pathway, leading to brain
tumors (86–88). Overexpression of Shh at E 10
in the dorsal tube of transgenic mice, after the
dorsoventral patterning of the CNS, provokes
a blocking of SVZ neuroepithelial cells in a
non-differentiated state (89), suggesting that
Shh may prevent differentiation of neural stem
cells, or derived progenitors. In support of
these observations, Shh stimulates in vitro the
proliferation of neural progenitors of the retina
(90) or the telencephalon (91). However,
whether stem cells are included in the pool of
proliferating cells is unclear.
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Other Factors Known to Influence NSC
Proliferation
In the previous section we saw that NSCs
require the presence of specific factors to sus-
tain cell survival and proliferation. Other fac-
tors modulate these cell states and participate
in the homeostasis of NSCs throughout devel-
opment. Indeed, analyses of the stem-cell pop-
ulation revealed that at high cell density some
secreted factors favor the expansion of stem
cells, suggesting that unidentified factors may
control NSC renewal (17). A paracrine action
on NSCs was also described for the developing
mouse cortex (38): we previously mentioned
that EGF-R expression increases in a temporal
manner in cortical explant cultures, allowing
the proliferation of EGF-responsive stem cells
(37). Interestingly, a co-culture with explants
derived from younger embryos prevents an
EGF-R increase, suggesting that secreted fac-
tors may delay stem-cell activation. The secret-
ing factor was identified as Bmp4, a bone
morphogenic protein that intervenes in the
dorsalization of the CNS (92–94). FGF-2 and
Bmp4 have antagonistic action on the appear-
ance of EGF-responsive stem cells (38). Know-
ing that FGF-2 is required for neuronal
formation, it is reasonable to theorize that
when FGF-2 is present in large amounts during
later stages of neurogenesis (95–97), it helps to
start the gliogenesis program by promoting the
appearance of EGF-R on NSCs, and overcomes
the inhibition of Bmp4. Bmp2 and Bmp4, as
well as their receptors, are also present in the
adult SVZ, their presence being associated to
neurogenesis inhibition (98). Noggin, a Bmp
inhibitor, is present in ependymal cells that are
adjacent to the SVZ. Bmp7 acts on the same
receptors as those recognized by Bmp2 and
Bmp4, and although it has a lower affinity for
Noggin, it decreases SVZ proliferation by 50%.
These experiments show that Bmps regulate
neurogenesis at the SVZ cell level throughout
development until adulthood.
EGF is not the unique ligand for the EGF-R.
TGFα is known to bind this receptor with high
affinity. The in vivo stem-cell cycle in the SVZ
was previously evaluated by H3-thymidin or
bromodeoxyuridine (BrdU) incorporation (99).
BrdU incorporation in TGFα–/– mice revealed
that NSC proliferation is reduced in the SVZ
lateral corner, a region known to contain the
NSCs at the origin of the neuroblasts populat-
ing the olfactory bulb. In TGFα knockout and
wild-type mice, the same number of stem cells
were isolated in vitro from the SVZ lateral cor-
ner (100). Studies of BrdU incorporation
reveals that the absence of TGFα produces a
lengthening of the NSC mitotic cycle. These
and the previous experiments discussed here
show that growth factors can independently
regulate NSC survival, proliferation, and cell-
cycle duration.
The ephrin family and their receptors was
first described to be involved in axon target-
ing (101), cell migration (102), and brain
boundary (103), and they may participate in
NSC regulation. No mitogenic action on
neural progenitors was reported until
recently. The Eph family is formed of 8 lig-
ands and 14 receptors. The adult SVZ con-
tains receptors for ephrin as well as the
Ephrins-B2/3, suggesting a role of the Ephrin
family in the SVZ cell state. Infusion of the
clustered ectodomain of Ephrin-B2 (an active
form of Ephrin) leads to increased prolifera-
tion in the SVZ, as shown by BrdU incorpora-
tion and a decrease of migratory neuroblasts
(104). An increase of astrocytes was simulta-
neously observed. Under these conditions,
astrocytes have the type-B cell phenotype
described as stem cells, showing that ephrin
can stimulate the proliferation of stem cells in
vivo. The ultimate demonstration that stem
cells are the target of Eprin-B2 should be
revealed by the in vitro stem-cell characteriza-
tion after in vivo ephrin infusion.
Several other factors may modulate stem-
cell proliferation; some of them enhance stem-
cell proliferation, and others inhibit it. The FL
ligand for the FLT3-receptor kinase was origi-
nally reported to stimulate hematopoietic
stem-cell proliferation. In a recent study, it was
observed that progenitors derived from neural
stem cells isolated from postnatal rats express
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the FLT3 receptor (105). When neurospheres
were incubated in the presence of EGF and
FGF-2 + FL and H3-thymidine, a decreased
proliferation was observed in comparison to
the stimulation with EGF + FGF-2. Because the
renewal capacity of the stem-cell population
was not challenged (for example, in Fig. 1) it is
difficult to conclude that stem-cell expansion
was inhibited by FL. Moreover, FL synergizes
with NGF to enhance dorsal-root ganglion
neuron survival, indicating that FL might con-
trol neuronal differentiation. In this hypo-
thesis, the decrease in proliferation of a
subpopulation of progenitor cells may reflect
the entry of neural precursors into G0 of the
cell cycle. The direct potential FL action on
stem cells has not yet been determined.
Other factors might control NSC—such as
TNFα, which increases proliferation in the
adult SVZ (106), or the ganglioside GM3,
which decreases BrdU incorporation in the
postnatal SVZ (107).
It appears that the control of the neural stem-
cell number during development depends on
the levels of various factors that control NSC
survival, proliferation, and cell state as well as
cell-fate determination. A picture of the tempo-
ral actions of these factors is beginning to
emerge. The understanding of how these factors
coordinate and influence the role of each other
will be the next challenge. Nonetheless, certain
links have already been identified.
Intrinsic Control of Stem-Cell Renewal
The previous sections mainly described the
action of epigenetic factors as well as some
potential intracellular regulatory mechanisms.
Several intrinsic factors that may control NSC
proliferation were also recently discovered,
but no links with known extrinsic factors act-
ing on stem cells have been identified so far.
One of these intrinsic factors is the transcrip-
tion factor Emx2. Homeodomain transcription
factors are involved in the control of body seg-
mentation, organogenesis, cell specification,
and differentiation. During development and
adulthood, some homeodomain transcription
factors are expressed in the neuroepithelium,
suggesting a possible NSC regulation by these
factors. One of them—Emx2—is expressed in
the germinal area (108–110) and in the SVZ of
the adult mouse brain (111). These observa-
tions suggest that Emx2 could play a role in
the regulation of neural progenitor prolifera-
tion or cell fate. In fact, Emx2 has region- and
age-specific action on neural progenitors.
Moreover, Emx2 can have opposite effects,
depending on the brain area where it is
expressed. Emx2 is expressed in neurospheres
derived from the adult mouse SVZ, but down-
regulated in differentiated cells, indicating
that progenitors or stem cells express Emx2
(111). Neural progenitors derived from Emx2
knockout mice show a greater ability to prolif-
erate in comparison to wild-type cells, and
these mice generate 50% less neuroblasts that
migrate through the rostral migrating stream,
suggesting that the undifferentiated state is
favored in the absence of Emx2. Using sub-
cloning analysis as described in Fig. 1, it was
shown that the presence of Emx2 reduced the
frequency of secondary stem-cell generation
(one stem cell generates less stem cells). This
effect is not related to a control on cell sur-
vival or on cell-cycle time, but appears to be
linked to the capacity of stem cells to divide
symmetrically or asymmetrically. By reducing
the generation of new NSC, Emx2 favors
asymmetric division of adult SVZ stem cells
(111). A completely opposite action of Emx2 is
described for the regulation of cortical multi-
potent progenitor cells: when Emx2 is overex-
pressed in vitro in cortical E14 progenitors
cultivated at low density, an increase of clone
size was observed (67), whereas no effect was
recorded when progenitor cells of the gan-
glionic eminence were transduced with Emx2.
This increase in cell number is not related to
an enhancement of survival, but to an increase
in cell proliferation by favoring symmetric
division, as attested by BrdU incorporations
and BrdU dilution throughout cell division.
This observation was confirmed by analyzing
stem cells in the cortical neuroepithelium of
knockout mice for Emx2. In these mice, the
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frequency of symmetric division is reduced by
30% (mitotic cell observation), whereas asym-
metric division is increased by 50% in com-
parison to wild-type animals showing a
switch in cell-fate decision. This switch is con-
firmed by the analysis of clones generated in
vitro. At E 14, the majority of clones are com-
posed of pure neurons, and only 25% are mul-
tipotent. When Emx2 is overexpressed in
vitro, 60% of the clones become multipotent
(67). It appears that Emx2 in the cortex
enhances stem-cell symmetric division and
instructs progenitor cells toward a multipo-
tential fate, whereas Emx2 favors asymmetric
division in the adult SVZ. These opposite
effects of Emx2 in different regions revealed
that other modulators interacting with Emx2
exist. We can speculate that Emx2 acts on dif-
ferent promoters. It would be of great interest
to reveal whether the regulation of Emx2
action at the promoter level is region-specific
and/or age-related.
Other intrinsic factors that are not directly
linked to the cell-cycle machinery have
recently been identified in the SVZ. The tran-
scription factor Sox2 is expressed in the inner
cell mass (where ES cells reside) of blasto-
cytes, and is ubiquitously present in the
neural tube during early developmental stage
(112). Some regulatory regions of the Sox2
gene drive the expression to the ventricular
zone, where progenitor cells are located. Neu-
rosphere isolation from transgenic mice that
expressed the β-galactosidase and the
neomycine transgenes under the activation of
the specific telencephalic regulatory element
of the Sox2 gene have revealed that the Sox2
gene is expressed in stem cells and derived
progenitors (113). Indeed, the transgene con-
struction contained a gene of resistance
against neomycine, so in vitro proliferation of
stem cells can be achieved in G418 only if the
transgene is expressed, showing that Sox2 is
specifically expressed in stem cells. Because
of its constant presence in NSC and in non-
differentiated cells throughout development,
Sox2 is likely to play an important role on the
stem-cell state.
Particularities of Adult Neural 
Stem Cells
Adult striatal stem cells conserve their
embryonic ability to respond to either EGF or
FGF-2 (23,33), whereas other regions respond
differently to environmental factors. The hip-
pocampus was also described as a region con-
taining stem cells. The subependyma
juxtaposing the hippocampus is supposed to
be the location for stem cells (114). The hip-
pocampal stem-cell amplification necessitates
the presence of FGF-2, serum, and high cell
density (24). In fact, conditioned medium
(resulting from high cell density) can be sub-
stituted by the cystatin-C protein (115). Cys-
tatin-C is secreted in cell cultures, providing a
neurotrophic factor necessary for stem-cell
division. Cystatin-C is a protease, but the neu-
rotrophic effect is determined by another
domain than the one implicated in proteoly-
sis. Moreover, the neurotrophic domain must
be glycosylated in order to allow mitogen
activity (115). As a result, hippocampal NSCs
can be isolated and propagated in the pres-
ence of FGF-2 and cystatin-C. The spinal cord
also presents a dependence on two factors to
induce its proliferation state. Indeed, the pres-
ence of both EGF and FGF-2 is required to
induce spinal cord stem cell proliferation
(116). Similar observations were made for
NSCs located around the third and fourth
ventricles. It appears that all NSCs in the cau-
dal region of the CNS require two factors for
their expansion (in addition to all the
unknown factors that are acting through an
autocrine or a paracrine mode). Interestingly,
the most rostral region of the brain—the
eye—contains stem cells that can be isolated
without EGF, or FGF-2 (25), but by adding
insulin and transferrin in the media. High
concentrations of insulin are known to mimic
the action of IGF-1 that is required for fetal
stem-cell proliferation (31). These observa-
tions suggest two possible mechanisms regu-
lating NSCs during adulthood: the retinal
stem cells may control their activity in an
autocrine manner, and the environment may
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provide inhibitory factors to prevent uncon-
trolled stem-cell proliferation. In fact, the
study of Tropepe et al. (25) has shown that in
the absence of EGF or FGF-2, retinal stem cells
release FGF-2. Indeed, blocking FGF-2 with
antibodies decreased the formation of neu-
rospheres by one-half. The possible autocrine
release of IGF-I must be investigated to
understand the molecular control of stem-cell
renewal. These studies indicate that stem cells
are regulated in a different manner from the
rostro-caudal axis of the CNS, with an
increasing dependence on factors necessary
for stem-cell proliferation: in vitro, the eye
NSC requires no exogenous mitogen for pro-
liferation, the telencephalic NSC needs EGF
or FGF-2, and the spinal cord NSC EGF and
FGF-2 (see Fig. 3). What is the origin of this
difference? Until now, the lineage relationship
between stem cells of the various brain areas
was unknown. All NSCs could be derived
from a homogenous pool of primitive stem
cells, and are then specified during rostro-
caudal induction. Another scenario could be
that certain NSCs forming the neural tube are
already committed to certain functions. The
differences between NSCs could be linked to
the evolution of the brain. During evolution,
the eye appeared very early, and is already
present in very primitive animals. Interest-
ingly, some animals have eyes without a
brain. For instance, the jellyfish Cladonema or
the scallops have primitive eyes directly con-
nected to a muscle (117). In one review,
Gehring suggests that the brain was formed
during evolution after the apparition of the
eye (117). These observations point out that
the origin of the eye is one of the most primi-
tive regions of the CNS. As a result, it is possi-
ble that the retinal stem cells may have
evolved differently from the other NSCs. The
understanding of the origin of the differences
between NSCs should reveal important
intrinsic mechanisms that regulate NSCs.
Intriguingly, the difference in growth-factor
responses of NSCs is present during adulthood,
but not during embryogenesis. At mid-gesta-
tion, NSCs of the retina, the telencephalon, and
the spinal cord can respond either to EGF or to
FGF-2 (Fig. 3). These observations show that all
along the lifespan, NSCs acquire new abilities
to respond to environmental signals. The role
of such changes from birth to adulthood is thus
far unclear.
Mammalian Neural Stem-Cell Renewal 85
Molecular Neurobiology Volume 27, 2003
Fig. 3. Neural stem cells are regulated differently throughout age and depending on the brain area. No data
concerning the isolation of NSCs at the time of neural tube formation are available, but from the studies of
Tropepe et al. (52) on embryonic stem cells, we can suggest that FGF-2 and LIF could be required for the acti-
vation of NSCs. At E8.5, telencephalic NSCs as well as spinal cord NSCs (at E10) can only be isolated with FGF-
2. Later, NSCs proliferate either after FGF-2 or EGF stimulations. In regard to the retina, only data concerning the
role of EGF are available. During adulthood, a strong difference in NSC responsiveness to mitogens is estab-
lished along the rostro-caudal patterning of the CNS. Indeed, in vitro isolation of retina NSCs does not necessi-
tate the presence of factors in the medium, whereas telencephalic NSCs require the presence of FGF-2 or EGF,
and for spinal cord NSCs, both.
Concerning the adult human brain, EGF and
FGF-2 are both required for the isolation of
multipotent neural stem cells/progenitors
(118–121). An approximate 100-fold increase of
the cell number in 20 d was observed when
neurospheres derived from the olfactory bulb
were expanded with EGF and FGF-2 (121).
However, a long-term renewal was only docu-
mented in the presence of cystatin-C (122),
allowing a 108 fold increase in cell number. It
remains unclear whether isolated neural prog-
enitor cells have characteristics of stem cells
related to long-term cell renewal and whether
these progenitors contain NSCs (multipotent).
Nonetheless, the use of cystatin-C make it pos-
sible to obtain a sufficient number of cells to
study neurogenesis derived from adult human
tissue. The fact that cystatin-C is only active in
its glycosylated form necessitates a cell line
expressing the protein under the correct iso-
form, rendering the access to this molecule still
complicated. It appears that during evolution
between rodents and humans, stem cells were
controlled by a more complex environment.
The Special Case of the Telomerase
To be considered as NSC, a cell must be
maintained in a non-differentiated multipoten-
tial state and proliferate. Proliferation potential
is one of the most essential characteristics for a
NSC to conserve its rank. This state depends
on an internal clock that regulates the lifespan
of a cell. It is obvious that cell renewal is tightly
linked to this potential, but the control of
neural-cell lifespan is poorly understood. At
each division, cells lose 8–12 bp on each chro-
mosome (123). To prevent alteration of the
genes located at the extremities of the chromo-
somes, a repetitive sequence, CCTTAG, is
added at each end by an enzyme known as
telomerase (124–126). The repeat of CCTTAG is
termed telomeric sequence. As cells proliferate
in vitro, telomeres become progressively
shorter (127,128). When telomeres disappear,
ends of chromosomes can fuse, provoking
recombinations of genes located at the extrem-
ities, and leading in some cases to cell transfor-
mation (129,130). To prevent this event, the cell
induces the senescence state and cell death
(131) through the activation of p19 and p16,
and then p53 (reviewed in ref. 132). The real
demonstration of the role of telomerase on cell
lifespan was shown in senescent fibroblasts by
transferring the gene coding for the catalytic
subunit of the telomerase, Tert, and thus,
inducing immortalization (133,134). Tert is still
present in the adult brain (cortex, eye, but not
the brainstem), although telomerase activity
decreases throughout development (135,136),
in accordance with the presence of neural
progeny. Telomerase activity is present in
rodent neural progenitors at early and late pas-
sages (137), showing that these cells maintain
the capacity to renew, and suggesting that
telomerase activity might be mainly located in
the stem-cell population. Interestingly, FGF-2
increases telomerase expression in mouse cor-
tical neural precursors (138), leading to the the-
ory that environmental factors may also
control telomerase activity in NSCs. Such
observation was not reported for human fetal
neurospheres, where a decrease in the telom-
erase activity was recorded from early culture
to passage 20 (137). But it is not known
whether the decrease is a result of the cell cul-
ture used, or if it is inherent to the population
studied. Because the loss of telomeres can
induce cell senescence, it would be interesting
to restore telomerase activity in fetal and adult
human neural progenitors in order to maintain
cell expansion and survival, and to thus have
material to study human neurogenesis.
Cell-Cycle Machinery and 
Stem-Cell Renewal
Cell-Cycle Arrest and Replicative
Senescence
Cell renewal implicates the control of the
cell-cycle entry. The cell cycle is activated when
the transcription factor of the E2F family is
separated from the tumor suppressor Rb,
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allowing E2F to transactivate genes necessary
for cell division (see Fig. 4). These two families
of molecules are the key regulators of cell pro-
liferation, and numerous other proteins partic-
ipate in their activation and inhibition. Indeed,
the unphosphorylated form of Rb inhibits E2F
action, whereas phosphorylation of Rb releases
E2F from Rb, allowing E2F action. Cell-cycle
entry depends on the cyclin D/cdk4/6 com-
plex that phosphorylates Rb on one site, and
progression of the cell cycle can be achieved
only when a second site of Rb is phosphory-
lated by the cyclin E/cdk2 complex. The tumor
suppressors p21/p27 prevent the activations of
both cyclin/cdk complexes, whereas p16
blocks the action of cyclin D/cdk4/6 only (for
review see ref. 139). Numerous other factors
are involved in cell-cycle control, but it is
important to note that three sets of tumor sup-
pressors can block the cell cycle transiently or
definitively. Irreversible growth arrest is
termed replicative senescence. A stop in cell-
cycle progression can be imposed by the p21
and p27 tumor suppressors, whereas replica-
tive senescence is caused by the expression of
p16 and p14 (p19 in mouse) and finally p53 to
induce cell death (140–142) (see Fig. 1, 2). p21
and p27 are more involved during the growth
of an organ, when cell proliferation is con-
trolled by the presence of mitogens or inhib-
ited by cell-cell contacts. Different signals can
lead to senescence-like trophic-factor removal,
telomere shortening (127,131,143,144), oxida-
tive damage (128,145,146), and oncogene acti-
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Fig. 4. This simplified schema shows the key controls of cell proliferation: the transcription factors of the E2F
family induce cell proliferation only when it is separated from the tumor suppressor Rb. Indeed, the unphos-
phorylated form of Rb inhibits E2F action, whereas phosphorylation of Rb releases Rb from E2F, allowing E2F
proliferation induction. Entry into the cell cycle depends on the cyclin D/cdk4/6 complex (upper part of the fig-
ure) that phosphorylates Rb on one site, and progression of the cell cycle can be achieved only when a second
site of Rb is phosphorylated by the cyclin E/cdk2 complex. The tumor suppressor p21/p27 prevents the activa-
tion of both cyclin/cdk complexes, whereas p16 blocks the action of cyclin D/cdk4/6 only.
vation (141,147,148). These alterations can
potentially lead to cell transformation and
oncogenicity. As a result, an irreversible
growth arrest (and often cell death) is a protec-
tion against tumorigenicity. It also appears that
if the cell-culture medium is not optimal, cells
can enter senescence because of free radical
attacks or the absence of neurotrophic factors.
The following sections outline approaches that
attempt to identify which tumor suppressors
are involved in the control of stem cell/prog-
enitor renewal. Contrary to common beliefs,
the cell cycle is not regulated in a homoge-
neous manner in all cells. Numerous tumor
suppressors control the cell cycle, and recent
data in developmental biology have revealed
that specific tumor suppressors only act in spe-
cific cells. Here, I present data from studies
that reveal that different functions of neural
stem cells in the brain and the retina are con-
trolled by different tumor suppressors.
Pten and Brain Growth
The Pten tumor suppressor is a phosphatase
of phosphatidylinositol-triphosphate that can
antagonize the mitogenic effect of certain mito-
gens that act through the PI-3 kinase-signaling
pathway (for review, see ref. 149). Pten is ubiq-
uitously expressed during CNS development,
suggesting a potential role for this protein in
brain-growth control (150,151). Confirming
this hypothesis, the Pten gene is often mutated
in glioblastoma (152). The excision of the Pten
gene in Pten-lox+ transgenic mice by the Cre-
recombinase gene controlled by the nestin pro-
moter induces the loss of Pten expression in
neural progenitors at mid-gestation. The loss
of Pten inhibition results in a larger brain
growth because of increased cell proliferation
in the ventricular zone and decreased cell
death (153). Isolation of stem cells by the neu-
rosphere approach has revealed that mutant
mice have approx 70% more stem cells in com-
parison to controls and that knockout neu-
rospheres contain 6.5 times more stem cells, as
shown by a stem-cell renewal assay (153).
These data clearly show that Pten controls
stem-cell renewal by inhibiting proliferation.
Inhibition of p53 and Rb leads 
to Neural-Cell Immortalization: 
The SV40 large T-antigen
When the conditions necessary for mouse
embryonic cerebellar or hippocampal progeni-
tor expansion were still unknown, blocking of
the tumor suppressors p53 and Rb was per-
formed to allow cell proliferation. The inhibi-
tion of p53 and Rb was achieved using the
temperature-sensitive allele of SV40 large T-
antigen (154): cells transduced with Sv40 large
T proliferated at 33°C, and cell stimulation
stopped at 39°C. The multipotentiality of
clonogenic hippocampal cell lines was tested
using transplantation procedures in neuro-
genic brain sites such as the neonatal hippo-
campus and cerebellum (155). After
transplantation, grafted cells harbored either a
glial (astrocyte and oligodendrocyte) or a
neuronal morphology, showing that these cells
are derived from a multipotent progenitor
(155,156). It is probable that the primary neural
cultures expressed p53 and Rb because of inap-
propriate culture conditions capable of main-
taining progenitor survival and proliferation.
It is not clear whether Sv40 acts on the NSC
population or on other progenitors. Interest-
ingly, Sv40 large T failed to allow the estab-
lishment of a human neural-cell line from
progenitors derived from neurospheres that
originated from fetuses (157). These results
suggest that human neural multipotent prog-
enitor/stem cells are controlled by other tumor
suppressors under these conditions.
p27 and Neural Cell Immortalization
Various tumor suppressors could be
involved in the regulation of NSCs. Moreover,
the expression of tumor suppressors appears
to have a specific pattern. Interestingly, in the
adult mouse, p27 appears to regulate the cell
cycle of the transit-amplifying progenitors of
the SVZ but not of stem cells, whereas p19 con-
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trols the proliferation of neuroblasts (158). It
appears that different populations of progeni-
tors have their cell cycle controlled by different
tumor suppressors. It is important to deter-
mine whether these proteins are expressed in a
similar pattern (p19 in neuroblasts) in other
areas of the brain and in cultured stem cells
and derived progenitors, because they could
serve as specific markers to determine subpop-
ulations in nestin-positive cells.
The retina also exhibits a different expres-
sion pattern of tumor suppressors, depending
on the cell phenotype (for review, see ref. 159).
For instance, the tumor suppressor p57 is
expressed by a subpopulation of amacrine cells
(160), whereas p27 is found in the proliferative
zone and persists in Müller cells (161,162). Mis-
expression of p27 leads to premature differenti-
ation, showing that p27 regulates the retinal
progenitor cell-cycle exit. These results suggest
that the exit of stem cells from the mitotic cycle
is regulated according to the neuronal pheno-
type they will generate. However, contrary to
Xenopus (163), there is no evidence that cell fate
depends on the identity of the tumor suppres-
sor expressed,
It appears that by controlling p27 expression,
it is possible to increase or repress neural prog-
enitor proliferation. Several studies reported
the induction of neural-cell division by mimic-
king the action of c-Myc (157,164,165). c-Myc is
known to activate the cell cycle through the
inhibition of p27 action by different mecha-
nisms. First c-Myc can induce the expression of
a p27-sequestering protein (166). Second, it
may prevent the interaction of p27 with the
cyclinE-cdk2 complex (see ref. 167). In addi-
tion, c-Myc can induce the expression of cyclin
E, leading—after several steps—to the release
of p27 from the cyclinE-cdk2 complex and thus
allowing cells to enter the mitotic cycle (168).
Confirming these actions, the deregulated,
enhanced expression of Myc genes is linked to
tumor proliferation in various cell types
(169–171). Some viruses contain homologs of c-
Myc in their genome. The viral homolog of c-
Myc, v-Myc, has first been identified as the
transforming element in the MC29 avian-trans-
forming retrovirus. The molecular action of v-
Myc seems to be similar to those linked to c-
Myc function (reviewed in ref. 172).
The expression of v-Myc by the MC29 retro-
virus in primary chicken fibroblasts or murine
and avian hematopoietic cells provokes the
transformation of these cells (173–175). In con-
trast, the transfer of v-Myc has virtually no
action on adrenocortical cells (176). These
results show that each cell type determines its
cell-cycle progression with different levels of
controls. Regarding the CNS, v-Myc has no
effect on quiescent retinal cells (177). Interest-
ingly, it was recently shown that c-Myc expres-
sion can stimulate telomerase expression (178),
suggesting, that in certain cases, c-Myc can
lead to immortalization through telomerase
activity. Moreover, the c-Myc level is increased
after prolonged hTert expression, provoking a
positive feedback loop even after the removal
of the hTert transgene (134). Such an effect has
not yet been tested in neural progenitors.
Nonetheless, the proliferation of cerebellar
neural progenitors can be definitively estab-
lished by v-Myc expression only (165). This
series of data suggests that Myc stimulates the
proliferation of neural progenitors, but does
not reprogram proliferation in cells that are
definitively post-mitotic. Similar results were
obtained with human fetal neural progenitors
that overexpress v-Myc, the cell-doubling rate
of which was accelerated and maintained con-
stant under stimulations of exogenous mito-
gens (157,179,180). No tumorigenic properties
of this cell line were reported (157). Interest-
ingly, the differentiation capacity seems to be
unaltered by the expression of the oncogene
(181–183). Murine and human fetal neural
progenitors immortalized by v-Myc can differ-
entiate into neurons and glia once injected into
the developing mouse brain or the adult rat
striatum, respectively (165,181–183). In fact,
the effect of v-Myc on neural-cell fate determi-
nation is not a clear-cut action. Other studies
revealed that v-Myc can interfere with differ-
entiation. Hippocampal neural progenitors
genetically engineered with v-Myc controlled
by an inducible promoter differentiate only
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when v-Myc is shut down (164). The level of v-
Myc in various studies on neural cells may
explain the differences observed for the action
of v-Myc on differentiation.
This series of data shows that the level of
stimuli needed to increase progenitor prolifer-
ation is a subtle balance between renewal and
maintenance of cell differentiation. Such a crit-
ical equilibrium was recently observed for
NSCs cultivated in the long term in the pres-
ence of EGF. After several passages, cells culti-
vated as neurospheres attach (approx 10
passages), lose their dependence on EGF to
proliferate (approx 27 passages), and acquire
characteristics of transformed cells. These
observations have revealed that constant mito-
genic stimulation of NSCs can lead to tumori-
genicity (184).
An understanding of the dosage of NSC
mitogens and inhibitors of tumor suppressors
is thus crucial in order to maintain NSC long-
term renewal without inducing cell transfor-
mation.
Perspectives
Interestingly, neural cells transduced with v-
Myc necessitate the presence of mitogens to
undergo sustained proliferation. This charac-
teristic provides an opportunity to explore the
mechanisms leading to self-renewal. One can
study gene expression (induction and repres-
sion) after v-Myc induction, and then the stim-
ulation by exogenous mitogens. Moreover,
comparisons of neural stem-cell gene-expres-
sion profiles could identify the genes that are
required for cell proliferation in neural progen-
itor and stem cells. This approach, combined
with those of various groups looking for gene-
expression homology in different stem cells
(e.g., hematopoietic, embryonic, or neural)
(185), may help to identify candidate genes.
Then, these genes could be investigated by in
situ hybridization to reveal their location and
temporal pattern of expression in order to
define whether this expression is compatible
with the location of stem cells and their func-
tions. Similar approaches have recently been
described using hematopoietic and neural
stem cells (185).
Another promising approach in the study of
the mechanism endowed by stem cells is the
use of nuclear transfer. The actual situation in
this domain seems to show that efficacy in
cloning after nuclear transfer is tightly linked
to the developmental state (differentiated cells
vs stem cells) of the donor nucleus (186). The
most primitive cell state seems to need less
genomic remodeling in comparison to adult
differentiated cells. The dissection of the genes
re-expressed after nuclear transfer in compari-
son to those already expressed (or even inac-
tive) in different cell-donor populations should
help to reveal important genes leading to self-
renewal.
The understanding of how to amplify stem
cells without inducing cell transformation rep-
resents a challenge to produce NSCs in order
to adequately study neurogenesis in vitro and
to produce safe NSCs for cell transplantation,
as well as to identify key mechanisms at the
origin of brain tumors.
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